Associated Papers
The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review.
Sun J et al.
Frontiers in Endocrinology, 2024
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
Libé R et al.
The Journal of Clinical Endocrinology and Metabolism, 2011
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
Bertherat J et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Heterogeneity of skin manifestations in patients with Carney complex.
Mateus C et al.
Journal of the American Academy of Dermatology, 2008
Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S et al.
The Journal of Clinical Endocrinology and Metabolism, 2008
PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L et al.
Pituitary, 2006
Select a paper to view details